Anti-Cytochrome P450 27A1 [V29-P4B8*B2]
Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited
- Datasheet
- References (2)
- Inventor Info
Info
Catalogue Number | 152599 |
Applications | ELISA IHC WB |
Antigen/Gene or Protein Targets | Cytochrome P450, Family 27, Subfamily A, Polypeptide 1 (CYP27A1), Sterol 27-Hydroxylase |
Reactivity | Human |
Relevance | Cytochrome P450 27A1 (CYP27A1) catalyzes the first step in the oxidation of the side chain of sterol intermediates; the 27-hydroxylation of 5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol. Has also a vitamin D3-25-hydroxylase activity. |
Host | Mouse |
Immunogen | Ovalbumin-conjugated synthetic peptide KVVLAPETGEL (C-terminal sequence) |
Positive Control | IHC: formalin-fixed, paraffin-embedded human sections; WB: Overexpression lysates |
Subclass | IgG1 kappa |
Notes |
For IHC perform antigen retrieval: microwave 20 min @ 800W in 10 mM citrate buffer, pH 6.0 This antibody was applied in a poster presented at the 2015 NCRI conference: http://abstracts.ncri.org.uk/?s=oxysterol&year_published=2015 |
Research Area | Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism |
References: 2 entries
Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer.
Europe PMC ID: 27341022
Swan et al. 2016. Oncotarget. :. PMID: 27341022.
IHC WB
Add a reference
References: 2 entries
Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer.
Swan et al. 2016. Oncotarget. :. PMID: 27341022.
IHC WB
Add a reference